Viewing Study NCT04831450


Ignite Creation Date: 2025-12-24 @ 5:21 PM
Ignite Modification Date: 2026-01-22 @ 4:08 PM
Study NCT ID: NCT04831450
Status: WITHDRAWN
Last Update Posted: 2022-08-04
First Post: 2021-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
Sponsor: University of Miami
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module